Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
About this item
Full title
Author / Creator
Lonn, Eva , Yusuf, Salim , Arnold, Malcolm J , Sheridan, Patrick , Pogue, Janice , Micks, Mary , McQueen, Matthew J , Probstfield, Jeffrey , Fodor, George , Held, Claes , Genest, Jr, Jacques , The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators and Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In epidemiologic studies, the plasma total homocysteine level has been found to be a risk factor for cardiovascular disease. In the HOPE-2 trial of high-risk patients, treatment with folic acid, vitamin B
12
, and vitamin B
6
reduced plasma total homocysteine levels. However, treatment with B vitamins was not associated with a reduction...
Alternative Titles
Full title
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67862152
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67862152
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa060900
